z-logo
Premium
A retrospective analysis of the risk factors for allergic reactions induced by the administration of oxaliplatin
Author(s) -
Yamauchi H.,
Goto T.,
Takayoshi K.,
Sagara K.,
Uoi M.,
Kawanabe C.,
Matsunaga M.,
Miyoshi T.,
Uchino K.,
Misumi N.,
Nishino T.
Publication year - 2015
Publication title -
european journal of cancer care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 67
eISSN - 1365-2354
pISSN - 0961-5423
DOI - 10.1111/ecc.12156
Subject(s) - medicine , oxaliplatin , dexamethasone , incidence (geometry) , allergic response , retrospective cohort study , allergic reaction , gastroenterology , allergy , colorectal cancer , cancer , immunology , immunoglobulin e , physics , antibody , optics
This study retrospectively investigated the clinical features and risk factors of allergic reactions induced by oxaliplatin administration. This study investigated the incidence of allergic reactions and analysed the background and laboratory data in patients with colorectal cancer treated with oxaliplatin‐based chemotherapy at K yushu M edical C enter between A pril 2012 and S eptember 2012. A total of 62 patients were included in this study. The number of patients in the allergic and non‐allergic groups was 7 and 55 respectively. The incidence of allergic reactions was 11.3%. We compared the patients' characteristics and laboratory data between the two groups and found that the average dose of dexamethasone in the allergic group was significantly lower than that observed in the non‐allergic group ( P  = 0.0111). Furthermore, the incidence of allergic reactions in the group that received prophylaxis of less than 12 mg of dexamethasone was significantly higher than that observed in the group that received more than 12 mg of dexamethasone ( P  = 0.0103). In conclusion, a lower dexamethasone dose is a possible risk factor for allergic reactions induced by the administration of oxaliplatin; however, given the retrospective design used in this study, further validation of this finding is warranted.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here